| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1993 Oxford University Press
OTHER |
Abnormal mRNA splicing resulting from three different mutations in the CFTR gene
Paediatric Molecular Genetics, Institute of Molecular Medicine, John Radcliffe Hospital Oxford OX3 9DU, UK
* To whom correspondence should be addressed
Received February 2, 1993; Revised March 24, 1993; Accepted March 24, 1993
Three different putative splicing mutations in the CFTR gene have been studied by analysing mRNA extracted from nasal epithelial cells harvested from patients with cystic fibrosis. Six patients were analysed, all of whom had classical symptoms of cystic fibrosis (CF). Two patients carried the 621+1G
T mutation, 3 patients carried the 17171G
A mutation and 1 patient carried the 1898+1G
A mutation. All patients carried the
F508 mutation on the other chromosome. Ten non-CF control subjects were also studied. The 621+1G
T mutation resulted in activation of an alternative splice site within exon 4 in one patient and activation of this site or skipping of exon 4 in the other patient. The 17171G
A mutation resulted in skipping of exon 11 in all 3 patients studied and the 1898+1G
T mutation resulted in skipping of exon 12. These experiments demonstrate that these mutations do result in aberrant splicing of CFTR mRNA as predicted from the changes in genomic sequence.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Haque, E. Buratti, and F. E. Baralle Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12 Nucleic Acids Res., November 12, 2009; (2009) gkp1040v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adamia, A. A. Reichert, H. Kuppusamy, J. Kriangkum, A. Ghosh, J. J. Hodges, P. M. Pilarski, S. P. Treon, M. J. Mant, T. Reiman, et al. Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia Blood, December 15, 2008; 112(13): 5111 - 5121. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pagani, C. Stuani, M. Tzetis, E. Kanavakis, A. Efthymiadou, S. Doudounakis, T. Casals, and F. E. Baralle New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12 Hum. Mol. Genet., May 15, 2003; 12(10): 1111 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schibler, I. Bolt, S. Gallati, M.H. Schoni, and R. Kraemer High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and {Delta}F508 Eur. Respir. J., June 1, 2001; 17(6): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||



